• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氟喹诺酮类药物曲伐沙星(CP 99,219)对医院分离菌的体外活性

In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates.

作者信息

Ling T K, Liu E Y, Cheng A F

机构信息

Department of Microbiology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, PR China.

出版信息

Chemotherapy. 1999 Jan-Feb;45(1):22-7. doi: 10.1159/000007161.

DOI:10.1159/000007161
PMID:9876206
Abstract

The susceptibility of 492 Enterobacteriaceae, 227 other gram-negative bacteria, 448 gram-positive bacteria and 108 anaerobic organisms was determined by the agar dilution method against trovafloxacin and other antibiotics. Trovafloxacin was highly active against most of the Enterobacteriaceae including Enterobacter spp. and Citrobacter spp. [minimum inhibitory concentration (MIC)90 <1 mg/l], Acinetobacter spp. and Pseudomonas aeruginosa (MIC90 = 0.25 and 2 mg/l, respectively). The antimicrobial activity was extended to the gram-positive bacteria including streptococci, Streptococcus pneumoniae, coagulase-negative staphylococci and methicillin-sensitive Staphylococcus aureus with MIC90 <1 mg/l. Enterococci and methicillin-resistant S. aureus were inhibited (MIC90 = 2 mg/l; sparfloxacin and ciprofloxacin were 16 and 64 mg/l, respectively). Almost all anaerobic organisms were inhibited by trovafloxacin (MIC90 = 1 mg/l).

摘要

采用琼脂稀释法测定了492株肠杆菌科细菌、227株其他革兰氏阴性菌、448株革兰氏阳性菌及108株厌氧菌对曲伐沙星和其他抗生素的敏感性。曲伐沙星对大多数肠杆菌科细菌具有高度活性,包括肠杆菌属和柠檬酸杆菌属(最低抑菌浓度(MIC)90<1mg/L)、不动杆菌属和铜绿假单胞菌(MIC90分别为0.25mg/L和2mg/L)。其抗菌活性还扩展至革兰氏阳性菌,包括链球菌、肺炎链球菌、凝固酶阴性葡萄球菌和甲氧西林敏感金黄色葡萄球菌,MIC90<1mg/L。肠球菌和甲氧西林耐药金黄色葡萄球菌受到抑制(MIC90 = 2mg/L;司帕沙星和环丙沙星的MIC90分别为16mg/L和64mg/L)。几乎所有厌氧菌都被曲伐沙星抑制(MIC90 = 1mg/L)。

相似文献

1
In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates.新型氟喹诺酮类药物曲伐沙星(CP 99,219)对医院分离菌的体外活性
Chemotherapy. 1999 Jan-Feb;45(1):22-7. doi: 10.1159/000007161.
2
Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.曲伐沙星对医院内革兰氏阳性和革兰氏阴性分离株的抗菌活性。
J Antimicrob Chemother. 1997 Jun;39 Suppl B:29-34. doi: 10.1093/jac/39.suppl_2.29.
3
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.曲伐沙星、环丙沙星、氧氟沙星及广谱β-内酰胺类药物对需氧血培养分离菌株的体外活性比较
Zentralbl Bakteriol. 1998 Dec;288(4):509-18. doi: 10.1016/s0934-8840(98)80070-4.
4
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.环丙沙星、左氧氟沙星、洛美沙星、氧氟沙星、培氟沙星、司帕沙星和曲伐沙星对呼吸道感染革兰氏阳性和革兰氏阴性病原体的体外活性。
J Antimicrob Chemother. 1997 Sep;40(3):427-31. doi: 10.1093/jac/40.3.427.
5
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.甲基哌嗪基氟喹诺酮CG 5501的活性:与其他氟喹诺酮类药物的比较
J Antimicrob Chemother. 1997 Apr;39(4):447-52. doi: 10.1093/jac/39.4.447.
6
In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.曲伐沙星及其他五种氟喹诺酮类药物的体外抗菌活性
Chemotherapy. 1998 Mar-Apr;44(2):85-93. doi: 10.1159/000007097.
7
Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.曲伐沙星(CP-99,219)对445株来自心内膜炎患者和其他血流感染患者的革兰氏阳性分离株的体外活性比较
Antimicrob Agents Chemother. 1997 May;41(5):1146-9. doi: 10.1128/AAC.41.5.1146.
8
In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.新型青霉烷SCH-34343及其他抗菌药物对癌症患者临床分离菌株的体外活性
Chemotherapy. 1986;32(6):506-14. doi: 10.1159/000238460.
9
The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria.曲伐沙星及其他九种抗菌药物对413株厌氧菌的体外活性
J Antimicrob Chemother. 1996 Aug;38(2):271-81. doi: 10.1093/jac/38.2.271.
10
In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.抗耐甲氧西林金黄色葡萄球菌头孢菌素头孢比普对近期源自欧洲的革兰氏阳性和革兰氏阴性分离株的体外活性谱
J Antimicrob Chemother. 2008 Mar;61(3):595-602. doi: 10.1093/jac/dkm492. Epub 2008 Jan 23.

引用本文的文献

1
A critical review of the fluoroquinolones: focus on respiratory infections.氟喹诺酮类药物的批判性综述:聚焦于呼吸道感染
Drugs. 2002;62(1):13-59. doi: 10.2165/00003495-200262010-00002.
2
Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia.严重社区获得性肺炎患者气道分泌物中的曲伐沙星浓度。
Antimicrob Agents Chemother. 2000 Jan;44(1):178-80. doi: 10.1128/AAC.44.1.178-180.2000.